Sarasota, FL -- (SBWIRE) -- 09/05/2017 -- Global Immunoassay Market: Overview
A biochemical test counts the concentration of a macromolecule in the solution by using antigen or antibody known as an immunoassay. Detected macromolecule is referred as the analyte, immunoassay count quantity of analytes in urine and serum for the medical and research purposes. It is also used in quantitative and qualitative radioactivity procedures in order to guarantee the accuracy of results, while particularity and high sensitivity immunoassays are used to speed up the reactions. They come in various variations and formats; it may run in multiple stages when added with reagents and separated at different points in the assay.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/immunoassay-market
Global Immunoassay Market: Growth Factors
Increasing occurrences of the infections and chronic disease and the growing use of immunoassays in oncology are factors that are propelling the market growth. The rapid analysis provided by the immunoassays supplement, technological advancements, and cost effectiveness anticipate fueling the immunoassay market. Various strategies are adopted by key manufacturers such as expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others, this may gain a strong foothold in the market. Growing medical industries have the requirement for detection of one or more protein present in the patient's blood or serum. Growth and development of the immunoassays market primarily depend on the development of novel assays in areas such as oncology, cardiology, and various autoimmune diseases, these assay will assist in enhancing market revenue. Emerging automation trend is major growth factor of the market and it will help reduce the labor cost.
Global Immunoassay Market: Segmentation
The immunoassays market is segmented based on application, technology, end user, and product & services. The application segment is classified into hematology, infectious disease, oncology, endocrinology, and cardiology. On the basis of technology, the market is fragmented into chemiluminescence, ELISA, PCR, colorimetric, ELISPOT, fluorescence, western blot, and rapid test. The end-user segment is bifurcated into biotechnology companies, academic research centers, clinical laboratories, pharmaceutical companies, hospitals, and blood banks. Depending on products & services, the market is divided into software services, reagents & kits, and analyzers.
Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/immunoassay-market
Global Immunoassay Market: Regional Analysis
Emerging market in the Asia Pacific region coupled with expanding pharmaceutical & biotechnology industries along with laboratory automation is expected to foster the immunoassay market in the near future. Establishment of well-developed healthcare infrastructure, rise in medical tourism, and increasing installation of immunoassay systems in diagnostic centers & research laboratories is expected to open new avenues in the Asia Pacific market. North America is expected to experience the highest market growth in coming years. Increasing use of immunoassays in toxicology tests and drug discovery also augment to the market growth. Growing preferences and popularity of non-invasive diagnostic techniques and rising need for reagents is projected to propel the global immunoassay market in Europe.
Global Immunoassay Market: Competitive Players
Key market players that are operating in the global immunoassay market include Bio-Rad Laboratories Inc., Roche Diagnostics Limited, Sysmex Corporation, Siemens Healthcare, and BioMrieux. Other influencing players are Dickinson & Company, Alere Inc., Abbott Laboratories, Becton, Beckman Coulter, and Ortho Clinical Diagnostics.
Browse detail report @ https://www.zionmarketresearch.com/report/immunoassay-market
Global Immunoassay Market: Regional Segment Analysis
The Middle East and Africa